Related Experiment Videos
Serum paraoxonase after myocardial infarction
A Ayub1, M I Mackness, S Arrol
1University Department of Medicine, Manchester Royal Infirmary, Manchester, United Kingdom.
Arteriosclerosis, Thrombosis, and Vascular Biology
|February 12, 1999
Summary
Patients experiencing myocardial infarction (MI) have significantly lower serum paraoxonase (PON1) activity and concentration compared to healthy individuals. This reduction in PON1, an enzyme associated with HDL
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Enzymology
Background:
- High-density lipoprotein (HDL) plays a protective role against LDL oxidation.
- Paraoxonase (PON1) is an enzyme within HDL believed to be responsible for its antioxidant activity.
- PON1 has been linked to the pathogenesis of atherosclerosis.
Purpose of the Study:
- To investigate the activity, concentration, and specific activity of PON1 in patients immediately after acute myocardial infarction (MI).
- To compare PON1 levels in MI patients with age- and gender-matched healthy controls.
- To assess changes in PON1 levels post-MI and explore potential explanations for observed differences.
Main Methods:
- Serum samples were collected from 50 patients upon hospital admission after acute MI and from 48 healthy controls.
- Measurements included PON1 activity, PON1 concentration, and PON1-specific activity.
- PON1 levels were re-evaluated in MI patients at day 42 post-MI.
Main Results:
- Serum PON1 activity and concentration were significantly lower in MI patients compared to controls.
- PON1-specific activity was significantly higher in MI patients, indicating a lower concentration relative to activity.
- PON1 activity showed a partial recovery by day 42 but remained lower than controls; concentration and specific activity did not significantly change post-MI.
Conclusions:
- Low serum PON1 activity in MI patients may be a consequence of the acute coronary event or a pre-existing condition.
- The primary explanation for reduced PON1 activity appears to be a decrease in serum PON1 concentration.
- Further studies are warranted to evaluate PON1 as a predictive risk factor for MI.